Facebook
Twitter
LinkedIn
Forward
Fundamentals in Urology Webcast Only (2022)
Specifically designed for anyone unable to get away from the office to attend the Live Course, the Webcast Only option delivers the same great content. Purchase of the Webcast features simultaneous presentation slides and audio recorded from the Live Course and includes access to online course materials.
Webcasts will be available to view on Wednesday, July 13, 2022.
The Fundamentals in Urology course is designed to apply basic science knowledge and principles in development of treatment algorithms. This course has been recently redesigned to meet the needs of the early career urology resident and includes two days of engaging didactic content. This option is ideal for those who are unable or prefer not to travel so that you can either participate at a location of your convenience or from the comfort of your own home.
Designed to be informative and interactive, the program has been designed with the following goals:
- Provide a standardized and foundational course for early career residents to introduce them to urology.
- Provide a course that complements the efforts of individual residency programs.
- Deliver a uniform curriculum to ensure baseline proficiency to improve patient safety.
- Provide an opportunity for early career residents to begin networking with peers.
Registration Fees
Membership Category | Registration Fee |
|---|---|
| Member | $525 |
| Non-Member | $655 |
Target Audience
- Early Career Urology Residents
Learning Objectives
At the conclusion of this course, participants will be able to:
Session 1: Residency 101
- Identify Characteristics and habits of stand-out interns and residents.
- Develop strategies for soliciting feedback.
- List the information and actions required to post an emergency OR case.
- Describe different types of crystalloid and colloid fluid composition.
- Cite resuscitative and maintenance fluid replacement strategies.
- Discuss common electrolyte deficiencies and intern repletion orders.
- Illustrate principles of fluid/ electrolyte management with common postoperative cases and clinical scenarios.
Session 2: GU Imaging for the Urology Resident and GU Trauma
Cite the basic principles of image acquisition with CT and MRI.
Describe the appearance of kidney, adrenal and bladder tumors on CT.
Describe the appearance of prostate cancer on MRI and review PI-RADS.
State the evaluation, staging and management of traumatic urinary tract injuries.
Session 3: Adult and Pediatric Emergencies
- Outline the evaluation, staging, and management of common genital injuries and emergencies.
- List the differential diagnoses for an acute scrotum and steps for management/execution of each diagnosis.
Session 4: Nephrolithiasis and Hematuria
Review GU anatomy pertinent to stone disease.
Define characteristics of patient with acute stone episode with colic and sepsis.
Describe Percutaneous Nephrolithotomy Procedure, indications, and complications.
Develop an understanding of the most recent AUA guidelines on Hematuria.
Define hematuria and its types.
Identify the possible causes of and risk factors for developing hematuria.
Determine the process of who, how and why to evaluate a patient with hematuria.
Describe the management and screening for patients with hematuria.
List catheter types and applications for patients with hematuria.
Session 5: Female Pelvic Medicine and Reconstructive Surgery (FPMRS)
- Identify the physiology and pathophysiology of bladder function and dysfunction.
- Characterize the bladder dysfunction present in specific neurological disease states.
- List the causes of urinary retention.
- Describe the principles behind urodynamics and the basic interpretation of urodynamic studies in common urological scenarios.
- Analyze the systematic evaluation and identification of various types of urinary incontinence (UI) and Pelvic Organ Prolapse (POP) in the outpatient setting in order to offer appropriate interventions for treatment.
- Diagnose the various types of urinary incontinence (UI) and Pelvic Organ Prolapse (POP).
- Measure UI severity and stage POP using the Pelvic Organ Prolapse Quantification System.
- Cite different methods of surgically treating stress urinary incontinence and POP.
Session 6: Bladder and Renal Oncology
- Describe the management of non-muscle-invasive and muscle invasive bladder cancer, and identify key complications of bladder cancer treatment.
- Apply knowledge learned to diagnose, evaluate, and manage patients with renal masses.
- Differentiate the biologic and clinical differences among the various benign and malignant renal tumor histologies.
- Apply diagnosis and management strategies for small renal masses, including partial nephrectomy, active surveillance and ablation.
- Discuss management options for large and/or advanced renal masses including nephrectomy, cytoreductive nephrectomy, systemic therapy.
- Employ strategies to detect and treat complications of kidney cancer treatments.
Session 7: Prostate Benign and Malignant
- Demonstrate knowledge of the medical and surgical management of BPH and urinary retention.
- Cite the different treatment options for localized prostate cancer.
- Identify the basics in ADT management.
- Cite the historical role of treatment in prostate cancer.
- Define how to categorize prostate cancer in advanced disease.
- Describe the mechanisms of action for all advanced prostate cancer medications.
- List the best treatments for each category of advanced prostate cancer based on NCCN criteria.
- Explain the role of genetic testing in advanced prostate cancer.
Session 8: Testis and Tools
Scrotal Edema
List the etiology and risk factors for scrotal edema.
Review evaluation of patients with scrotal edema.
Describe the management options available for scrotal edema
Hydrocele
Discuss the development anatomy and natural history of hydrocele.
Review evaluation of patients with hydrocele.
Describe the management options available for hydrocele.
Testicular Torsion
Identify the anatomical basis of testicular torsion.
Review evaluation of patients with testicular torsion.
Describe management of testicular torsion.
Hernias
List the various types of hernias.
Review evaluation of patients with hernia.
Describe the management options available for hernia.
Testicular Tumors
Identify risk factors for testicular cancer.
Recall the evaluation of patients with testicular cancer.
Describe the management options available for testicular cancer.
Minimally Invasive Urology
Recall the history of lasers in clinical use in urology.
Recite 2 different clinical indications for shock wave therapy in urology.
List the advantages of robotic surgery over laparoscopic surgery.
Session 9: Resident Panel
Devise strategies to incorporate wellness and stress mitigation into your daily life early on in your career.
Identify mentors and engage with them more than once on a consistent basis.
Create efficient pathways to streamline work to maintain productivity as more responsibility is undertaken.
FUNDAMENTALS IN UROLOGY
8–10 July 2022
Philadelphia, PA
| Program Agenda | |
|---|---|
| Friday, July 8, 2022 | |
| 7:00 – 8:00 a.m. | Registration & Continental Breakfast |
| 8:00 – 8:10 a.m. | Welcome/Housekeeping Notes Sammy E. Elsamra, MD, FACS; Tracey Krupski, MD, MPH; Nicole L. Miller, MD, FACS |
| Session 1: Residency 101 | |
| 8:10 – 8:40 a.m. | What Makes a Good Intern? Simone Thavaseelan, MD |
| 8:40 – 8:55 a.m. | Steps to Posting an Emergency OR Case Alexandra Tabakin, MD |
| 8:55 – 9:30 a.m. | Basics of Inpatient Care: Fluids, Pathways, and Recognizing Post-op Complications Gina Badalato, MD |
| 9:30 – 9:45 a.m. | Break |
| Session 2: GU Imaging for the Urology Resident and GU Trauma | |
| 9:45 a.m. – 10:45 a.m. | Fundamentals of CT Imaging and MRI Ethan Halpern, MD |
| 10:45 – 10:50 a.m. | Q&A |
| 10:50 – 11:50 a.m. | Adult GU Trauma 101: Blood at the Meatus, Hematuria, Kidney Fractures & More |
11:50 – 1:00 p.m. | Lunch Break |
| Session 3: Adult and Pediatric Emergencies | |
| 1:00 – 1:40 p.m. | Adult GU Trauma 201: Case Study in Priapism, Fornier’s, Penile Fracture, Testis Rupture Niels V. Johnsen, MD, MPH |
| 1:40 – 2:30 p.m. | Acute Scrotum in Pediatric Patient and Beyond |
| 2:30 – 2:45 p.m. | Break |
| Session 4: Nephrolithiasis and Hematuria | |
| 2:45 – 3:45 p.m. | Nephrolithiasis: Basic Overview with Focus on Acute Management of Septic Stone URS and PCNL Indications and Complications Sammy E. Elsamra, MD, FACS |
| 3:45 – 4:45 p.m. | Hematuria: AUA Guidelines and Catheter Ahmed Ghazi, MD, FEBU, MBBS |
| 4:45 – 5:30 p.m. | Tips and Tricks with Wires, Catheters and Trochars Sammy E. Elsamra, MD, FACS; Ahmed Ghazi, MD, FEBU, MBBS; Niels V. Johnsen, MD, MPH; Nicole L. Miller, MD, FACS |
| 5:30 – 5:45 p.m. | Course Evaluation/Adjourn |
| Saturday, July 9, 2022 | |
|---|---|
| 7:00 – 7:45 a.m. | Registration & Continental Breakfast |
| 7:45 – 8:00 a.m. | Raffle/Housekeeping Notes Sammy E. Elsamra, MD, FACS; Tracey Krupski, MD, MPH; Nicole L. Miller, MD, FACS |
| Session 5: Female Pelvic Medicine and Reconstructive Surgery (FPMRS) | |
| 8:00 – 9:05 a.m. | Neuro-urology and Different Reasons Why Urinary Retention Happens & A Primer on Urodynamics Gary Lemack, MD |
| 9:05 – 10:10 a.m. | Pelvic Organ Prolapse Jennifer Anger, MD, MPH |
| 10:10 – 10:25 a.m. | Break |
| Session 6: Bladder and Renal Oncology | |
| 10:25 – 11:15 a.m. | Bladder Cancer with Description of Pathology, Hematuria, TURBT and its Complications, BCGosis, Cystectomy with its Myriad of Complications Tracey Krupski, MD, MPH |
| 11:15 a.m. – Noon | Renal Masses: Benign and Malignant; Renal Cysts, AML, Small Renal Masses and Complications of Partial Nephrectomy/Ablation, Large Renal Masses/ Complications Mark Ball, MD |
| Noon – 1:00 p.m. | Lunch Break |
| Session 7: Prostate Benign and Malignant | |
| 1:00 – 1:55 p.m. | Prostate: Benign Review Urinary Retention in Men, Bladder Drainage, Treatments for BPH and Their Complications Nicole L. Miller, MD, FACS |
| 1:55 – 2:30 p.m. | Localized Prostate Cancer Primer Claire de la Calle, MD |
| 2:30 – 3:05 p.m. | Metastatic Prostate Cancer Michael B. Williams, MD, MS |
| 3:05 – 3:20 p.m. | Break |
| Session 8: Testis and Tools | |
| 3:20 – 4:05 p.m. | Testis: Benign and Malignant; Scrotal Edema, Hydroceles, Torsions, Hernias, and Testicular Tumors Sumit Isharwal, MD |
| 4:05 – 4:55 p.m. | Lasers, Laparoscopes, and Lithotripters: The Science of Minimally Invasive Urology Costas Lallas, MD |
| 4:55 – 5:30 p.m. | Resident Panel: Things I Wish I Had Been Told Early in Residency – Q&A Moderator: Tracey Krupski, MD, MPH |
| 5:30 – 5:45 p.m. | Course Evaluation/Adjourn |
Education Council Disclosures
Education Council Disclosures 2021
COI Review Work Group Disclosures
COI Review Work Group Disclosures 2021
For a full listing of all faculty disclosures, please visit Fundamentals in Urology Course Faculty Disclosures and click on the "Faculty" tab.
AUA Office of Education Staff has nothing to disclose.
All relevant financial relationships have been mitigated.
AUA ACCREDITATION INFORMATION
METHOD OF PARTICIPATION:
Learners will participate in this online educational activity by taking the pre-test, viewing the webcast and completing the post-test and evaluation. To claim CME credit for this enduring material, learners must complete the post-test, passing with 80% accuracy and submit the program evaluation.
Estimated time to complete this activity: 16 hours
Release Date: July 13, 2022
Expiration Date: July 13, 2025
ACCREDITATION:
The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION:
The American Urological Association designates this enduring material for a maximum of 16.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
OTHER LEARNERS:
The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
EVIDENCE BASED CONTENT:
It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA DISCLOSURE POLICY:
All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
MITIGATION OF IDENTIFIED CONFLICT OF INTEREST:
All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:
- Peer review for valid, evidence-based content by the AUA COI Review Work Group.
- Attestation that clinical recommendations are evidence-based and free of commercial bias.
- Introduction of a debate format (point-counterpoint)
- Inclusion of moderated panel discussion with unbiased moderator
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Divestiture of the relationship by faculty
- Recusal from controlling relevant aspects of planning
- Selection of alternative faculty for specific topic
OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:
The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
AUA PARTICIPANT INFORMATION & POLICIES:
Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.
Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.
Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.
Price
AUA Members save 25%! For more information on membership benefits, visit www.AUAnet.org/Join.
Webcast Only Pricing:
Membership Category | Registration Fee |
|---|---|
| Member | $525 |
| Non-Member | $655 |
Webcasts will be available to view on Wednesday, July 13, 2022.
CANCELLATION POLICY
AUA Education & Research reserves the right to cancel any portion of this activity if a minimum enrollment is not reached before May 31, 2022. If AUA Education & Research cancels any portion of this activity, notification will be sent by June 7, 2022.
Live Courses: An administrative fee of 15% is assessed if registration is cancelled up to six weeks prior to the course. If registration is cancelled four to six weeks from the course, the cancellation fee is 50% of the registration fee paid. No registration fees will be refunded less than four weeks prior to the course.
Webcast: Cancellations must be made no later than one week prior to the live course. Subscription fees will not be refunded after the cancellation period. Purchases after the live course date are not eligible for a refund.
Registration Transfer: Customers switching from an option of lesser value to a higher value will be required to pay the difference in cost between the two options. Switching to an option of lesser value from a higher value must be made no later than to six weeks prior to the course and will be subject to an administrative fee of 15% of the cost of the course from which they are transferring. Transfer of registration from a higher value option to an option of lesser value past six weeks prior to the course will not receive a refund.
Cancellations must be made in writing. Requests may be made via mail or fax to 410-689-3912. Questions? Call 1-800-908-9414 or email registration@AUAnet.org.
ATTENDEE INFORMATION & POLICIES
AUA Anti-Harassment Policy: AUA Commitment: AUA is committed to providing a safe and productive meeting environment that fosters open dialogue and the exchange of scientific ideas and is free of harassment and discrimination. All meeting participants are expected to behave professionally and treat others with respect, follow venue rules, and alert AUA staff or security of any dangerous situations or anyone in distress.
Reporting Harassment: It is the policy of the AUA that all meeting participants will enjoy an environment free from discrimination, harassment or retaliation. Harassing or offensive behavior by meeting participants will not be tolerated. If an individual experiences or witnesses harassment, he or she should contact Janet Skorepa, AUA EVP, at jskorepa@AUAnet.org or Diane Bieri, AUA General Counsel, at dbieri@AUAnet.org or use a venue phone and ask for security if he or she feels unsafe. All complaints will be treated seriously and responded to promptly.
The AUA reserves the right to take any action deemed necessary and appropriate, including refusing or revoking the registration of any individual, without refund, as long as such refusal is consistent with applicable law and AUA policy.
Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the American Urological Association (AUA).
Consent to Use of Photographic Images: Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities.
Audio, Video, Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.
Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA.
Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, a written request should be submitted at least one month in advance. For additional assistance with your request please call 1-800-908-9414.